Correlation Between Unicycive Therapeutics and Avax Techs

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Avax Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Avax Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Avax Techs, you can compare the effects of market volatilities on Unicycive Therapeutics and Avax Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Avax Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Avax Techs.

Diversification Opportunities for Unicycive Therapeutics and Avax Techs

-0.74

Correlation Coefficient

Unicycive Therapeutics  Avax Techs

Pay attention - limited upside

The 3 months correlation between Unicycive and Avax is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Avax Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avax Techs and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Avax Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avax Techs has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Avax Techs go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Avax Techs

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.45 times more return on investment than Avax Techs. However, Unicycive Therapeutics is 2.21 times less risky than Avax Techs. It trades about 0.23 of its potential returns per unit of risk. Avax Techs is currently generating about -0.12 per unit of risk. If you would invest  38.00  in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of  40.10  from holding Unicycive Therapeutics or generate 105.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Avax Techs

Unicycive Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Avax Techs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avax Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Unicycive Therapeutics and Avax Techs

The main advantage of trading using opposite Unicycive Therapeutics and Avax Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Avax Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avax Techs will offset losses from the drop in Avax Techs' long position.

The idea behind Unicycive Therapeutics and Avax Techs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.